{"entity":{"id":"chk1-inhibitor-payloads","kind":"term","name":"CHK1 inhibitor payloads","aka":["CHK1i ADC payloads","checkpoint kinase 1 inhibitor cargo"],"tldr":"A CHK1-inhibitor conjugate carries a drug that interferes with a replication-stress checkpoint. A published conference abstract reports a HER2-directed preclinical example.","summary":"CHK1 inhibition is the cargo mechanism only when the inhibitor is physically attached to the conjugate. The AACR 2026 abstract describes engineered-cysteine trastuzumab, a cleavable linker and a CHK1-inhibitor payload. The investigators tested cells and a HER2-positive breast-cancer xenograft model. This establishes a publicly described payload design and model experiment, separate from giving an oral checkpoint inhibitor alongside another ADC. It does not establish human safety, benefit after a TOP1 ADC or a treatment-selection rule.","asOf":"2026-11-08","links":[{"label":"Halazonetis et al.: CHK1-inhibitor conjugate, AACR 2026 abstract 1714","url":"https://doi.org/10.1158/1538-7445.am2026-1714"},{"label":"2020 antibody versus peptide radiosensitizer delivery experiment","url":"https://pubmed.ncbi.nlm.nih.gov/32304937/"},{"label":"Meng et al.: exatecan/prexasertib pair screening, AACR D3 abstract A067 (2026)","url":"https://doi.org/10.1158/1557-3265.d32026-a067"},{"label":"ClinicalTrials.gov: separate prexasertib/cetuximab administration in NCT02124148","url":"https://clinicaltrials.gov/study/NCT02124148"}],"tags":[],"related":["adc","atr-chk1-inhibitors","replication-stress","synthetic-lethality","adc-analytes-and-exposure"],"cancers":[],"sections":[],"technologies":[],"targets":["chek1"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["The antibody delivery antigen and the payload’s checkpoint target answer different questions. The proposed advantage depends on sufficient intracellular release and checkpoint dependence, not a HER2 or replication-stress label alone. The conference abstract reports limited model safety observations; lack of mouse weight loss cannot establish human marrow safety or a clinical therapeutic window.","An earlier 2020 study attached the checkpoint inhibitor AZD7762 to an antibody. The conjugate recognized the tested cell-surface target but lacked efficacy in that delivery experiment; the investigators pursued protease-activated cell-penetrating peptides instead. Physical attachment and target binding therefore did not establish a useful intracellular effect. This negative result does not establish that every CHK1-directed conjugate must fail.","The 2026 A067 conference abstract screened exatecan with prexasertib in cancer-cell and blood-progenitor assays. It proposes a candidate pair for dual-payload development; the abstract does not itself document both chemicals attached to a tested antibody. Pairwise synergy, a constructed dual-cargo product and a patient therapeutic window are separate claims.","NCT02124148 lists prexasertib and cetuximab as separately administered drugs with different schedules. It is not evidence of a cetuximab conjugate carrying a CHK1 inhibitor. Registry design, observed pharmacodynamic changes and patient outcomes also require separate interpretation."],"category":"ADC chemistry"},"route":"/terms/chk1-inhibitor-payloads/","neighbours":{"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"},{"id":"atr-chk1-inhibitors","kind":"technology","name":"ATR and CHK1 inhibitors","route":"/technologies/atr-chk1-inhibitors/"}],"pathway":[{"id":"replication-stress","kind":"pathway","name":"DNA replication stress","route":"/pathways/replication-stress/"}],"term":[{"id":"adc-analytes-and-exposure","kind":"term","name":"ADC analytes and exposure","route":"/terms/adc-analytes-and-exposure/"},{"id":"synthetic-lethality","kind":"term","name":"Synthetic lethality","route":"/terms/synthetic-lethality/"}],"target":[{"id":"chek1","kind":"target","name":"CHEK1","route":"/targets/chek1/"}]}}